首页> 美国卫生研究院文献>Mayo Clinic Proceedings >Endothelial Nitric Oxide Synthase Gene Variation Associated With Chronic Kidney Disease After Liver Transplant
【2h】

Endothelial Nitric Oxide Synthase Gene Variation Associated With Chronic Kidney Disease After Liver Transplant

机译:肝移植后与慢性肾脏病相关的内皮型一氧化氮合酶基因变异

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVE: To identify single nucleotide polymorphisms (SNPs) associated with risk of developing chronic kidney disease (CKD), a prevalent comorbidity, after liver transplant (LT).PATIENTS AND METHODS: This study consists of a cohort of adult (≥18 years) primary-LT recipients who had normal renal function before LT and who survived 1 year or more after LT at a high-volume US LT program between January 1, 1990, and December 31, 2000. Patients with adequate renal function (estimated glomerular filtration rate, ≥40 mL/min per 1.73 m2 during follow-up; n=308) and patients with incident CKD (estimated glomerular filtration rate, <40 mL/min per 1.73 m2 after LT; n=92) were identified. To investigate the association of 6 candidate genes with post-LT CKD, we selected SNPs that have been associated with renal function in the literature. Hazard ratios were estimated using Cox regression, adjusted for potential confounding variables.RESULTS: The variant allele (298Asp) of the Glu298Asp SNP in the endothelial nitric oxide synthase gene (NOS3) was significantly associated with CKD after LT (P=.05; adjusted for multiple comparisons). The 5-year incidence of CKD was 70% among patients homozygous for the NOS3 variant allele (298Asp) compared with 42% among those not homozygous for the NOS3 variant allele. Specifically, homozygosity for the NOS3 variant allele conferred a 2.5-fold increased risk of developing CKD after LT (P=.005, adjusted for confounding variables).CONCLUSION: Homozygosity for the variant allele of NOS3 (298Asp) is associated with CKD after LT and may be useful for identifying recipients at higher risk of post-LT CKD.
机译:目的:确定单核苷酸多态性(SNPs)与肝移植(LT)后患慢性肾脏病(CKD)的风险(一种合并症)有关。患者与方法:本研究由一组成年人(≥18岁)组成在1990年1月1日至2000年12月31日期间,通过大量的美国LT计划,在LT前肾功能正常且在LT后存活1年或更长时间的原发性LT接受者。肾功能适当的患者(肾小球滤过率估计值,随访期间每1.73 m 2 ≥40 mL / min; n = 308)和发生CKD的患者(估计的肾小球滤过率,每1.73 m 2 <40 mL / min)<在LT之后; n = 92)。为了研究6个候选基因与LT后CKD的关联,我们选择了在文献中与肾功能相关的SNP。结果:内皮一氧化氮合酶基因(NOS3)中Glu298Asp SNP的变异等位基因(298Asp)与LT后的CKD显着相关(P = .05;经校正)以进行多个比较)。在纯合NOS3变异等位基因(298Asp)的患者中,CKD的5年发病率为70%,而在非纯合NOS3变异等位基因的患者中为42%。具体来说,NOS3变异等位基因的纯合性使LT后CKD发生风险增加2.5倍(P = .005,针对混杂变量进行了调整)结论:NOS3变异等位基因(298Asp)的纯合性与LT后CKD相关可能有助于识别出发生LT后CKD风险较高的接受者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号